A Guide to Market Access for Healthcare Products: The Power of the Global Value Dossier

Unleash the power of interactive global value dossiers

Explore the ways interactive Global Value Dossiers (iGVDs) streamline market access by combining clinical, economic, and real-world evidence into a dynamic, stakeholder-friendly format.

Market access for healthcare products is challenging – but with the right tools, you can transform complexity into clarity. Discover how interactive Global Value Dossiers (iGVDs) can revolutionize the way you communicate value to stakeholders, ensuring your products gain the visibility they deserve.

In this guide, Market Access Managers, HEOR Specialists and Medical Affairs Professionals will learn:

How to combine clinical, economic, and real-world data into a compelling narrative

How iGVDs enable you to adapt quickly to market changes, keeping your content relevant and up to date

How digital tools like BaseCase make your dossiers dynamic, engaging, and accessible across devices

About the author

Vangelis Kominatos

Customer Success Consultant

Vangelis is a software professional with over 5 years of experience in the industry. For the past 3 years, he has been working as a consultant at the BaseCase group at Certara. He has worked closely with Market Access and HEOR professionals to help them achieve their business objectives using the BaseCase platform.

Vangelis brings a unique combination of technical expertise and customer-focused approach to his work, which has helped to establish him as a trusted advisor to clients.

Download the guide

Submit the form below to download your guide and learn all about interactive global value dossiers

About Certara

Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, and regulatory expertise to create a future where treatments reach patients faster and more efficiently.

From discovery to market access and commercial, we tailor solutions to meet our clients’ most pressing challenges. Through strategic leadership and advanced predictive technologies, Certara provides comprehensive solutions to optimize drug development processes, reduce risks, and improve outcomes. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.